This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

C-Kit

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What C-Kit Means in Everyday Medical Language

C-Kit is a protein found on the surface of many different cells in the body. It works like a receiver that binds to a substance called stem cell factor (SCF). When SCF attaches to C-Kit, it sends signals inside the cell that encourage certain blood cells to grow and develop. This process is important for normal blood cell production and other cell functions. C-Kit is also known as CD117 or stem cell factor receptor, which are different names for the same protein.

Why C-Kit Can Matter in Cancer Care

In some cancers, such as gastrointestinal stromal tumors (GIST) and melanoma, C-Kit may be found in higher amounts or in altered forms. These changes can affect how cancer cells grow and survive. Because of this, testing for C-Kit in tumor tissue can help doctors confirm the type of cancer and guide treatment decisions. Some treatments target C-Kit directly to block its signals and slow cancer growth. However, C-Kit is only one piece of information among many that doctors use to understand and manage cancer.

What Patients Might See or Hear About C-Kit

Patients might hear the term C-Kit, CD117, or stem cell factor receptor during discussions about biopsy results, pathology reports, or treatment plans. It may also appear in medical records or clinical trial descriptions. Seeing C-Kit mentioned does not automatically mean a cancer is aggressive or untreatable. It is a marker that helps identify certain cancer cells but does not tell the whole story about the disease.

How Doctors Use C-Kit in Diagnosis and Treatment Planning

Doctors test tumor tissue for C-Kit to help confirm a diagnosis, especially for cancers like GIST and melanoma. If a tumor tests positive for C-Kit, it may respond to specific therapies that target this protein. Testing for C-Kit is part of a larger process that includes imaging, other lab tests, and clinical evaluation. Understanding whether C-Kit is present helps doctors choose the best treatment approach for each patient.

Common Confusions and Questions About C-Kit

The different names for C-Kit—such as CD117 and stem cell factor receptor—can be confusing because they all refer to the same protein. Patients may wonder what C-Kit means for their specific cancer and treatment options. It is important to remember that C-Kit is just one factor in cancer care. Its presence or absence does not provide a complete picture of the cancer or prognosis.

Questions to Ask Your Care Team

If C-Kit testing is mentioned, patients can ask their healthcare team what the results mean for their diagnosis and treatment. Questions might include whether the tumor’s C-Kit status affects treatment choices, if there are therapies that target C-Kit, and how this information fits with other test results. Your care team can provide explanations tailored to your situation and help you understand the next steps.

Understanding C-Kit in Context

C-Kit is a helpful marker used in some cancers but not all. Its presence or absence is one part of a larger diagnostic and treatment process. Patients should use information about C-Kit as a starting point for conversation with their doctors rather than a final answer. Every patient’s situation is unique, so it is important to discuss your specific case with your healthcare providers.

Safety and Next Steps

This information about C-Kit is educational and not a substitute for medical advice. It cannot decide what is safe or appropriate for any individual patient. If you have questions about C-Kit or related tests, your care team can provide detailed explanations and guide you through your diagnosis and treatment options. Understanding C-Kit can help you feel more informed and involved in your care decisions.

Sources

Public source information used for this glossary entry includes: